Transcriptomic and Neurotransmitter Insights Into Gray Matter Volume Changes From 1 Hz rTMS in Treating Schizophrenia With Auditory Verbal Hallucinations
Acta Psychiatrica Scandinavica · 2025
DOI: 10.1111/acps.70014 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Acta Psychiatrica Scandinavica, 2025. Verfasst von Yuanjun Xie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Military Medical Psychology School, Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Schizophrenia, Transcranial Magnetic Stimulation, Gray Matter, Hallucinations. Die Arbeit nennt 175 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Shaanxi Province, Natural Science Basic Research Program of Shaanxi Province.
Abstract (Originalsprache)
Background
Auditory verbal hallucinations (AVH) are prominent positive symptoms of schizophrenia that frequently prove resistant to conventional antipsychotic treatments. Low‐frequency repetitive transcranial magnetic stimulation (rTMS) has emerged as a promising intervention for AVH; however, the underlying neurobiological mechanisms mediating its efficacy remain incompletely understood.
Methods
In this study, schizophrenia patients with AVH were randomly assigned to either an active stimulation group or a sham control group. The active stimulation group received 1 Hz rTMS targeting the left temporoparietal junction (TPJ), while the sham group underwent an identical procedure without actual stimulation. Structural MRI scans were conducted before and after treatment to evaluate changes in gray matter volume (GMV). Further analyses examined associations between GMV changes and both gene expression profiles and neurotransmitter receptor densities.
Results
Active rTMS stimulation resulted in a significant reduction in AVH symptoms and was associated with increased GMV in specific cortical regions related to sensory and cognitive processing. These structural changes correlated with gene sets enriched in neuroplasticity‐related pathways, such as cell morphogenesis, chromatin remodeling, and vesicle cytoskeletal trafficking. Notable changes were also observed in neurotransmitter receptor densities, particularly for serotonin (5HT1a), dopamine (D1), and glutamate (mGluR5) receptors. Multiple linear regression analysis identified specific hub gene expressions, such as ANK1, and patterns of neurotransmitter density, especially mGluR5, as significant predictors of GMV changes following rTMS stimulation.
Conclusion
Low‐frequency rTMS induced GMV changes, coupled with alterations in gene expression and neurotransmitter receptor densities, contribute to symptom alleviation in schizophrenia patients with AVH. These findings support rTMS as a promising intervention for targeting the neurobiological substrates underlying AVH in schizophrenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Military Medical Psychology School, Fourth Military Medical University, Xi'an, China.
- Department of Radiology, Fourth Military Medical University, Xi'an, China.
- Deparment of Mental Health, Xi'an Medical College, Xi'an, China.
- Department of Psychiatry, Fourth Military Medical University, Xi'an, China.
- Innovation Research Institute, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
- Military Medical Innovation Center, Fourth Military Medical University, Xi'an, China.
ORCID-Profile: Yuanjun Xie
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Shaanxi Province
- Natural Science Basic Research Program of Shaanxi Province
Zitieren
APA
Xie, Y., Li, C., Guan, M., Zhang, T., Ma, C., Wang, L., Li, X., Li, Y., Wang, Z., Wang, H., & Fang, P. (2025). Transcriptomic and Neurotransmitter Insights Into Gray Matter Volume Changes From 1 Hz rTMS in Treating Schizophrenia With Auditory Verbal Hallucinations. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.70014
Vancouver
Xie Y, Li C, Guan M, Zhang T, Ma C, Wang L, et al. Transcriptomic and Neurotransmitter Insights Into Gray Matter Volume Changes From 1 Hz rTMS in Treating Schizophrenia With Auditory Verbal Hallucinations. Acta Psychiatrica Scandinavica. 2025. doi:10.1111/acps.70014
BibTeX
@article{Xie2025,
author = {Xie, Yuanjun and Li, Chenxi and Guan, Muzhen and Zhang, Tian and Ma, Chaozong and Wang, Lingling and Li, Xinxin and Li, Yijun and Wang, Zhongheng and Wang, Huaning and Fang, Peng},
title = {Transcriptomic and Neurotransmitter Insights Into Gray Matter Volume Changes From 1 Hz rTMS in Treating Schizophrenia With Auditory Verbal Hallucinations},
journal = {Acta Psychiatrica Scandinavica},
year = {2025},
doi = {10.1111/acps.70014}
}
EUVIMED